Products – ATLASense Biomed

Product

The Next-Generation of Health Surveillance

REPHAEL comes into its own whenever pro-active and preventive-care matter. As the world’s only remote health monitoring platform to provide a 1-3-day prediction of ARDS and respiratory insufficiency, as well as early detection of Sepsis; REPHAEL empowers medical teams to prevent premature deaths and improve patient quality of life.

Creating an unprecedented impact

Cardiovascular real-time continuous screening

Any Where , Continuous
Replacing dozens of expensive monitoring modalities

The only and Earliest warning for Acute Respiratory Failure

Total potential savings to the public of 77% or $176,137 per year per patient

Sepsis Early Screening

25% reduction on overall Mortality 1.5 million savings in monthly average in hospital

REPHAEL platform, comes in, when pro-active and preventive-care matters!

Remote Health Surveillance Monitoring – end-to-end solution.
We offer an improved process of comprehensive, round-the-clock, personalized, wireless,
remote monitoring; everywhere. Our proprietary analytics software interprets the unique
collected data, transforming it into a potent and actionable tool in the early detection of deterioration, enabling better preventive care and achieving improved clinical and financial
results.

Turning the data collected into meaningful clinical insights through AI and early detection algorithms

Personalized
Continuous
Remote
Monitoring

Machine
Learning
Analysis

Early
Detection/
Prediction

Clinical decision
support toolPrediction
Timely
prevention
intervention

Improved
Clinical
Outcomes &
Financial Results

Acute Respiratory Failure Prediction

77% Total potential savings to the public

Our new marker enables detection and provides warning of the first 4 stages out of 6 deterioration stages.

Unique changes in the EMG spectrum of the respiratory muscles data and algorithm (the earliest stage)

The 6 stages of respiratory deterioration

Sepsis Early Screening

Under development by ATLASense in collaboration with Laura Inc. Brazil, the REPHAEL platform
is designed for the prediction of patient health deterioration and life-threatening events, as
well as for early detection and prevention of Sepsis – the number 1 cause of death in hospitals
and nursing homes.

Laura’s AI-based software is commercially implemented in over 25 leading hospitals in Brazil. The Sepsis early recognition application results in a 25% reduction in mortality and saves each hospital $2M per annum on average.

Won the Israel Innovation Authority grant for developing the next generation AI-based solution for early detection of Sepsis

Performed in collaboration with Laura, a leading Brazilian AI company

RAPHAEL platform, comes-in, when
pro-active and preventive-care matters!

Remote Health Surveillance Monitoring – end-to-end solution We offer an improved process of comprehensive, round-the-clock, personalized, wireless, remote monitoring; everywhere. Our proprietary analytics software interprets the unique collected data, transforming it into a potent and actionable tool in the early detection of deterioration, enabling better preventive care and achieving improved clinical and financial results.

RAPHAEL platform, comes-in, when pro-active and preventive-care matters!

ATLASense develops next generation of remote health surveillance, the RAPHAEL platform. It is based on proprietary all-in-one non-invasive continuous remote monitoring end-to-end solution to identify the very first signals of deterioration at 10th of the cost of use compared to any other system.

Respiratory Insufficiency Index (RII)

Currently the standard of care diagnosis methods for ARDS and for respiratory insufficiency, identified by capnograph and a blood saO2 monitor or by intrusive blood tests are all in failure already! Predicts Respiratory Failure 1-3 days before critical event, to avoid the need of COPD COVID-19, and other pulmonary ill patients from being connected to ventilation machine.

Warning on Early signs of Sepsis

Failure to recognize the onset of deterioration that happens very fast (6-12 hours), makes Sepsis the #1 cause of death in hospitals and nursing homes. Granted by the Israeli Innovation authority, collaborating with LAURA (Brazil), our solution is based on a proven AI software, already commercially implemented in over 25 hospitals with results of 25% reduction in mortality and saving each hospital $2M yearly on-average.